Daiichi Sankyo
Brooke Ehlen has extensive experience in account management and sales within the pharmaceutical industry, currently serving as Senior Associate Director of Oncology Account Management for Market Access at Daiichi Sankyo, Inc. since April 2005. Previous roles at Daiichi Sankyo include National Field Trainer, Associate Director, and various managerial positions in sales across multiple specialties. Prior to this, Brooke Ehlen worked as a Senior Account Executive at Leo Burnett and as an Account Executive at McCann Erickson. Brooke Ehlen earned a Bachelor of Arts in Marketing from Michigan State University, attending from 1996 to 2000, and graduated from Bishop Foley Catholic High School in 1996.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.